… the neurodegenerative process as well as levodopa-induced dyskinesia, and that anti-inflammatory/neuromodulatory drugs …

… Switzerland based pharmaceutical company has turned to a US charity to support its drug development programme as it … mid-stage clinical trial for its experimental treatment for Parkinson’s disease. The move comes as a growing number of … by the actor who named the organisation and who himself has Parkinson’s disease, raises about $50m a year for funding, …

… When should I start it? Does it cause involuntary movement (dyskinesia)? Will it stop working eventually? More than 50 …

… much medication, including one which is sometimes caused by dyskinesia, the uncontrollable movements often associated …

… AFQ056/mavoglurant for Parkinson’s disease levodopa-induced dyskinesia. His current position is vice president of …

… factor ∆FosB in the development of levodopa-induced dyskinesia in non-human primates. Research in Dr. Berton’s …